Tumor suppressor genes

Results: 649



#Item
31Vol 444 | 30 November 2006 | doi:nature05268  LETTERS Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Vol 444 | 30 November 2006 | doi:nature05268 LETTERS Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Add to Reading List

Source URL: molbio.unige.ch

Language: English - Date: 2011-06-08 05:03:13
32DOI:.CANPhosphorylation of ATR-Interacting Protein on Ser239 Mediates an Interaction with Breast-Ovarian Cancer Susceptibility 1 and Checkpoint Function Monica Venere, Andrew Snyder, Omar Zghei

DOI:.CANPhosphorylation of ATR-Interacting Protein on Ser239 Mediates an Interaction with Breast-Ovarian Cancer Susceptibility 1 and Checkpoint Function Monica Venere, Andrew Snyder, Omar Zghei

Add to Reading List

Source URL: molbio.unige.ch

Language: English - Date: 2011-06-08 05:03:14
33Watson School 2011 graduates Amy Rappaport Cornell University National Institute of Health Predoctoral Trainee and Barbara McClintock Fellow “Dissecting tumor suppressor and tumor maintenance genes in poor prognosis ac

Watson School 2011 graduates Amy Rappaport Cornell University National Institute of Health Predoctoral Trainee and Barbara McClintock Fellow “Dissecting tumor suppressor and tumor maintenance genes in poor prognosis ac

Add to Reading List

Source URL: www.cshl.edu

Language: English - Date: 2014-07-02 16:45:36
    34April 14, 2015 Dear Colleagues, Please find below details of a clinical study just opened to patient accrual at the Northwestern Medicine Developmental Therapeutics Institute (NMDTI). STARRS Study: Selinexor Treatment of

    April 14, 2015 Dear Colleagues, Please find below details of a clinical study just opened to patient accrual at the Northwestern Medicine Developmental Therapeutics Institute (NMDTI). STARRS Study: Selinexor Treatment of

    Add to Reading List

    Source URL: dti.nm.org

    Language: English - Date: 2015-04-14 16:42:08
    35Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

    Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

    Add to Reading List

    Source URL: www.ro-journal.com

    Language: English
    36025-042_08_SAR_Res:05_CSHL_Research_MA:03 AM Page 25  Research 025-042_08_SAR_Res:05_CSHL_Research_MA:03 AM Page 26

    025-042_08_SAR_Res:05_CSHL_Research_MA:03 AM Page 25 Research 025-042_08_SAR_Res:05_CSHL_Research_MA:03 AM Page 26

    Add to Reading List

    Source URL: cshl.org

    Language: English - Date: 2012-12-20 12:05:27
    37Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

    Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

    Add to Reading List

    Source URL: www.biomedcentral.com

    Language: English
    38BMC Cancer  BioMed Central Open Access

    BMC Cancer BioMed Central Open Access

    Add to Reading List

    Source URL: www.math.ku.dk

    Language: English - Date: 2012-01-27 08:04:21
    39From a Natural Product to a Fully Synthetic Clinical Development Candidate

    From a Natural Product to a Fully Synthetic Clinical Development Candidate

    Add to Reading List

    Source URL: www.epo-berlin.com

    Language: English - Date: 2014-07-16 05:07:53
    40Proteomics Clin. Appl. 2013, 7, 1–7  1 DOIprca

    Proteomics Clin. Appl. 2013, 7, 1–7 1 DOIprca

    Add to Reading List

    Source URL: clic-imaging.com

    Language: English - Date: 2014-03-26 11:42:10